RDNT Q1 2026 Earnings EPS Misses Estimates by Wide Margin NFBK Q1 2026 Earnings EPS Beats Estimates as Net Interest Margin Holds Steady XOMA Q1 2026 Earnings Royalty Revenue Challenges Lead to EPS Miss Stock Slips Verrica Pharmaceuticals Q1 2026 Earnings EPS Miss Amid PreRevenue Stage Stock Rises 271 XPON Q2 2025 Earnings Strong EPS Beat Highlights Cost Discipline Bowman Consulting Group Ltd Q1 2026 Earnings Significant EPS Miss Sends Mixed Signals